1939. Who to Boost When: An Analysis of Dosing Interval and Age on COVID-19 Outcomes in the COVE Trial During the Delta and Omicron Waves

BACKGROUND: The effects of age and interval between vaccine doses on COVID-19 are incompletely understood, yet critical for public health policy. METHODS: This analysis evaluated the effectiveness of an mRNA-1273 50 μg booster (3(rd) dose) in ∼17,000 boosted participants in the phase 3 coronavirus e...

Descripción completa

Detalles Bibliográficos
Autores principales: Follmann, Dean, Wang, Xiaowei, Gilbert, Peter, Baden, Lindsey R, El Sahly, Hana M, Essink, Brandon, Marovich, Mary, Janes, Holly, Deng, Weiping, Priddy, Frances, Dixit, Avika, Tomassini, Joanne, Das, Rituparna, Miller, Jacqueline, Zhou, Honghong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678540/
http://dx.doi.org/10.1093/ofid/ofad500.2470

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678540/
http://dx.doi.org/10.1093/ofid/ofad500.2470

Ejemplares similares